# Nexlizet

NDC: 72426-818
Generic name: Bempedoic Acid and Ezetimibe
Labeler / Manufacturer: Esperion Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200309

FDA application: NDA211617

## Active ingredients

- BEMPEDOIC ACID: 180 mg/1
- EZETIMIBE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72426-818"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72426-818
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fa2108c-0300-47b8-9d34-f762af7c93c6